Overview

Optivate in People With Von Willebrand Disease Undergoing Surgery

Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
An open, multi-centre study in patients with von Willebrand Disease (VWD) undergoing surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Bio Products Laboratory
Treatments:
Factor VIII